Florida report criticizes returns on biotech research subsidies; Forma partners with TGen;

@FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech

@JohnCFierce: Quintiles (CRO) is expanding in China, building a regional HQ in Shanghai. Release | Follow @JohnCFierce

@RyanMFierce: Roche does an encore Alzheimer's deal with AC Immune worth up to $420M, focused on anti-Tau antibodies. More | Follow @RyanMFierce

> The Orlando Sentinel raises questions about the payback Florida received from the state's ambitious effort to subsidize the launch of new institutes for drug discovery as some of the new ventures fail to deliver on all the jobs which were promised. Story

> Forma Therapeutics and TGen Drug Development--TD2--today announced an agreement to jointly develop new cancer therapies. Release

> Chemical & Engineering News has an in-depth portrait on Immunogen and the long road traveled by antibody-drug conjugates. Story

> Birmingham, AL-based Soluble Therapeutics has won a $1 million NIH grant to develop new protein formulation technology for drug developers. Story

Pharma News

@FiercePharma: China's pharma industry blames toxic capsules on super-aggressive tendering, says corner-cutting won't stop. Report | Follow @FiercePharma

> FDA keeps door open to pharmacy versions of KV's Makena. More

> Biotest prepared to exit Greece for non-payment. Story

> Cipla chief aims for more cut-rate cancer drugs. Article

Medical Devices News

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Oxford Immunotec pulls in $28M to boost TB Dx test. Story

> How can the FDA fix its device-approval process? Article

> Industry may be overstating effect of device tax. More

Biotech IT News

> Harvard IDs key human-hosted bugs with computer systems. More

> Third Rock fuels $41M launch of Bay Area biotech. Item

> Africa goes mobile to tackle drug safety woes. Story

And Finally... Researchers from the University of Houston have concluded that the most contaminated item you'll find in a hotel room is the TV remote. Release

 

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.